PDSB – pds biotechnology corporation (US:NASDAQ)
Stock Stats
News
PDS Biotech Leadership to Participate in March Conferences
PDS Biotechnology Co. (NASDAQ: PDSB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer
PDS Biotech Announces up to $22 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
PDS Biotech Announces Positive Clinical Data Demonstrating Compelling Survival and Clinical Responses in Recurrent/Metastatic HPV-Associated Cancers Published in JAMA Oncology
Form 8-K PDS Biotechnology Corp For: Mar 07
Form 4 PDS Biotechnology Corp For: Feb 28 Filed by: Freitag Gregory Gene
Form 4 PDS Biotechnology Corp For: Feb 28 Filed by: Glover Stephen C.
Form 8-K PDS Biotechnology Corp For: Feb 26
Form 424B5 PDS Biotechnology Corp
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.